We are delighted to share that expansion of our global bonded depot network continues. We have successfully received the bonded depot license this week for our Serbia facility. This opens a route for imports of bulk shipments and distribution from our depot in Serbia...
As Oximio patient centricity services continue to expand, we are delighted to announce that the first home healthcare visit in Israel took place week commencing 9th of January 2023. The services allow for the nurses to collect the bio-samples from the patients’...
Following the announcement of 8th December 2022, the Board of Oximio confirms the appointment of Mykola Nikolaiev as the new Chief Executive Officer (CEO). Accordingly, Krisztina Varga has resigned from the Board as CEO and Mykola Nikolaiev takes over the...
Following the crisis in Ukraine, Oximio has resumed some operations, knowing that previously established supply chains and logistics models are no longer feasible. This is given to the destruction of infrastructure, stock limitations, and most importantly, as we...
The new clinical trial logistics hub reaches research sites in East, Central and West Africa faster and at a reduced cost, compared with established supply chain models Huntingdon, United Kingdom (March 10, 2022) – Oximio is changing the landscape of clinical trials...
